Shanghai, China, 26 June, 2013 -Veolia Water Solutions & Technologies China (Veolia) recently took part in VacChina 2013, China's largest vaccine event covering the full value chain, which attracted nearly 200 executives from vaccines R&D and manufacturing sites in Shanghai. In addition, Veolia organized a roadshow in Shanghai and Suzhou that reached more than 40 MNCs.
Through these two events, Veolia shared with the audience its comprehensive offerings covering process water, waste water, reuse and laboratory water, as well as its environmental vision to reduce manufacturing impact. Veolia also presented its specific capabilities to meet the Chinese GMP 2010: Purified Water (PW), Ultra Purified Water(UPW) and Water for Injection (WFI) validated and packaged systems.
Veolia's unique solutions for pharmaceutical companies include:
- ORION® packaged systems that are pre-validated and skid-mounted. ORION® uses state of-the-art technologies, reverse osmosis coupled with electro deionization (CEDI), to produce Purified Water according the latest Pharmacopoeias. ORION®'s technology features 80 standard options to meet the Chinese market's needs.
- POLARIS®, Veolia's brand for multi-effect, vapor compression distillers and clean steam generators, which fits various needs in Biotech, Vaccines and Pharmaceuticals for Water for Injection. POLARIS®' falling film (MED) and compressor (VCD) technologies insure maximum efficient energy operation. POLARIS® meets the high demanding expectations of Vaccine manufacturers by complying with GMP, GAMP, FDA, CE & ISPE standards.
The Chinese government recently announced the "Biological industry's twelfth five-year development plan" that seeks to increase China pharmaceutical industry's capabilities.Meanwhile, with the implementation of the new GMP in 2011, China-operated vaccine companies are forced to comply with this new standard of manufacturing and quality assurance. Veolia has solutions to help China-based Pharmaceutical clients to meet the new GMP standard requirements with world-class systems that incorporate water- and energy-saving features, while optimizing running costs.
Laurent Cuny, Vice President of Veolia Water Solutions & Technologies China Industrial underlines "Pharmaceutical industry is a key market to target regarding the high challenges of waste water treatment and the impacts of the new regulations for the MNC's. We are very proud to support our clients in China by providing the best of breed technologies and dedicated services, to build sustainable and customized treatment plants to meet their growing business and production needs."